Activation of AMPK Attenuated Cardiac Fibrosis by Inhibiting CDK2 via p21/p27 and miR-29 Family Pathways in Rats
Authors:
Open Access
- 1 September 2017
- journal article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 8, 277-290
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Heilongjiang Province (H2015108, DQWLD201603, DQ2014-02)
- Harbin Medical University
This publication has 32 references indexed in Scilit:
- The origin of fibroblasts and mechanism of cardiac fibrosisJournal of Cellular Physiology, 2010
- Metabolism, cell growth and the bacterial cell cycleNature Reviews Microbiology, 2009
- Biological Functions of miR-29b Contribute to Positive Regulation of Osteoblast DifferentiationJournal of Biological Chemistry, 2009
- The Cyclic GMP Modulators YC-1 and Zaprinast Reduce Vessel Remodeling Through Antiproliferative and Proapoptotic EffectsJournal of Cardiovascular Pharmacology and Therapeutics, 2009
- MicroRNA-133 controls cardiac hypertrophyNature Medicine, 2007
- The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2Nature Medicine, 2007
- Distinct Roles of Autophagy in the Heart During Ischemia and ReperfusionCirculation Research, 2007
- A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failureProceedings of the National Academy of Sciences, 2006
- AMP‐activated protein kinase – development of the energy sensor conceptThe Journal of Physiology, 2006
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001